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REVIEW / SYNTHE`SE
Exercise and MEF2–HDAC interactions
Sean L. McGee
Abstract: Exercise increases the metabolic capacity of skeletal muscle, which improves whole-body energy homeostasis
and contributes to the positive health benefits of exercise. This is, in part, mediated by increases in the expression of a
number of metabolic enzymes, regulated largely at the level of transcription. At a molecular level, many of these genes
are regulated by the class II histone deacetylase (HDAC) family of transcriptional repressors, in particular HDAC5,
through their interaction with myocyte enhancer factor 2 transcription factors. HDAC5 kinases, including 5’-AMP-activated
protein kinase and protein kinase D, appear to regulate skeletal muscle metabolic gene transcription by inactivating
HDAC5 and inducing HDAC5 nuclear export. These mechanisms appear to participate in exercise-induced gene expression
and could be important for skeletal muscle adaptations to exercise.
Key words: gene expression, skeletal muscle, HDAC5, AMPK, PKD.
Re´sume´ : L’activite´ physique augmente la capacite´ me´tabolique du muscle squelettique et, de ce fait, ame´liore l’home´o-
stasie e´nerge´tique de tout l’organisme et contribue aux bienfaits apporte´s pour la sante´. Ces adaptations de l’organisme
sont en partie me´die´es par l’augmentation de l’expression d’un certain nombre d’enzymes du me´tabolisme dont la re´gula-
tion s’exerce dans la transcription. Au niveau mole´culaire, plusieurs de ces ge`nes sont sous le controˆle de la classe II des
histone-de´sace´tylases (HDAC) qui agissent comme des re´presseurs de la transcription, et notamment la HDAC5 kinase qui
agit de concert avec les facteurs de transcription MEF2. Les HDAC kinases (AMPK et PKD) semblent re´guler la transcrip-
tion du ge`ne me´tabolique dans le muscle squelettique par l’inactivation de HDAC5 et son exportation nucle´aire. Ces me´ca-
nismes sont probablement implique´s dans l’expression des ge`nes cause´e par l’exercice physique et jouent probablement un
roˆle important dans les adaptations du muscle squelettique a` l’exercice physique.
Mots-cle´s : expression ge´nique, muscle squelettique, HDAC5, AMPK, PKD.
[Traduit par la Re´daction]
Introduction
Exercise produces a number of bioenergetic adaptations in
skeletal muscle that ultimately increase the capacity of this
tissue to produce adenosine triphosphate (ATP). Such adap-
tations result in improved maintenance of energy homeosta-
sis at a whole-body level and contribute to the positive
health benefits of exercise. The mechanism by which exer-
cise induces these adaptations is, in part, mediated by acute
transcriptional regulation of a number of metabolic enzymes
in skeletal muscle. Exercise is known to increase the expres-
sion of enzymes involved in substrate transport, carbohy-
drate metabolism, beta oxidation, and the electron transport
chain. This is mediated largely at the level of transcription
(Hood et al. 2006). As these pathways play key roles in
both performance and metabolic disease, there has been con-
siderable interest in understanding how these gene networks
are regulated. A number of putative stimuli have been impli-
cated in the adaptive response of skeletal muscle to exercise.
These include perturbations in cellular energy balance asso-
ciated with increased ATP turnover, and also elevations in
intracellular calcium concentration as a result of excitation-
contraction coupling (Ojuka 2004). However, few studies
have identified molecular mechanisms involved in these re-
sponses. Analysis of the regulatory promoter regions of
various exercise responsive genes reveals that many pos-
sess a binding region for the myocyte enhancer factor 2
(MEF2) family of transcription factors. Beyond embryo-
genesis, the MEF2 family includes isoforms A, C, and D,
and although expressed in a number of tissues, they are
most highly expressed in muscle cells. They form homo-
dimers and heterodimers that bind AT-rich DNA sequences
to regulate numerous biological processes (McKinsey et al.
2002a). Metabolic genes that possess confirmed MEF2
binding sites on their promoters include the peroxisome
proliferator activated receptor gamma coactivator-1 (PGC-
1) (Czubryt et al. 2003), glucose transporter isoform 4
(GLUT4) (Thai et al. 1998), uncoupling protein 3 (Acin et
al. 1999), carnitine palmatoyl transferase 1 (Moore et al.
2003), and various cytochrome c oxidase subunits (Lenka
et al. 1998). Given the important role that MEF2 plays in
myoblast differentiation into myotubes, it might seem ob-
vious that many of these genes expressed in muscle are
regulated by MEF2. However, it is clear that acute regula-
tion of MEF2 in the post-differentiated state following cell
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cycle withdrawal can regulate MEF2-dependent gene ex-
pression (McKinsey et al. 2002a) and could be an impor-
tant control point for skeletal muscle adaptation in
response to exercise.
Regulation of MEF2
MEF2 regulation has been extensively studied in models
of cardiac hypertrophy and T-cell proliferation. In the basal
state, MEF2 is physically associated with members of the
class IIa histone deacetylases (HDACs), which inhibit
MEF2-dependent transcription via remodeling of surround-
ing chromatin. The class IIa HDACs catalyze the deacetyla-
tion of lysine residues within the chromatin-forming histone
proteins, creating positively charged side chains that form
tight electrostatic interactions with the negatively charged
DNA phosphate backbone. This ensures that transcriptional
coactivators and other enzymes required for transcription,
such as RNA polymerase, are denied access to the surround-
ing region of DNA, resulting in repression of MEF2-
dependent transcription (McKinsey et al. 2002a). This
process is opposed by histone acetyltransferases (HATs),
which acetylate histone lysine side chains and remove their
positive charge, effectively disrupting the electrostatic and
physical histone and DNA interaction. This grants tran-
scriptional machinery access to DNA and allows MEF2-
mediated transcription to proceed. The rate of transcription
at any given moment appears to be a balance of HDAC
and HAT activities (McKinsey et al. 2001). The numerous
roles of HDACs in biological function are only just emerg-
ing; however, aberrant regulation of HDAC activity is as-
sociated with cardiac hypertrophy and cardiac sudden
death (Olson et al. 2006). Furthermore, HDAC inhibitors
are currently being tested in clinical trials for certain can-
cers (Kim et al. 2003). Initial characterization of HDAC5,
a class IIa HDAC highly expressed in skeletal muscle,
showed that HDAC activity is highly controlled by phos-
phorylation. Specifically, phosphorylation of S259 and
S498 on HDAC5 dissociates HDAC5 from MEF2 and pro-
vides binding sites for 14–3-3 chaperone proteins that ex-
port HDAC5 from the nucleus via a chromosome region
maintenance 1-dependent mechanism (McKinsey et al.
2000). The subsequent reduction in MEF2-associated
HDAC activity allows MEF2-dependent transcription to
Fig. 1. Exercise-induced gene expression through regulation of HDAC5. Exercise increases intramuscular AMP concentrations that allow
activation and phosphorylation of AMPK by LKB1 and other AMPK kinases. AMPK translocates to the nucleus, where it can then phos-
phorylate S259 and S498 on HDAC5. This results in HDAC5 dissociating from MEF2 and HDAC5 nuclear export via 14–3-3 proteins.
Other alternate HDAC5 kinases include PKD, MARK2, and CaMKII (through local nuclear calcium signaling). Solid lines denote estab-
lished steps, whereas steps signified by dashed lines are yet to be validated in the regulation of metabolic genes in skeletal muscle. Abbre-
viations: AMP, adenosine monophosphate; AMPK, AMP-activated protein kinase; AMPKK, AMP-activated protein kinase kinase; CaMKII,
calmodulin-dependent protein kinase II; DAG, diacylglycerol; HDAC, histone deacetylase; InsP3, inositol 1,4,5 triphosphate; LKB1, serine/
threonine kinase; MARK2, microtubule affinity regulated kinase 2; MEF2, myocyte enhancer factor 2; P, phosphorus; PKC, protein kinase
C; PKD, protein kinase D; PLC, phospholipase C.
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proceed. HDAC5 activity can also be regulated by allos-
teric interactions with activated calmodulin (Berger et al.
2003) and Gbg proteins (Spiegelberg and Hamm 2005).
Analysis of the other class IIa HDAC isoforms 4, 7, and 9
suggests that these regulatory mechanisms are conserved
among this family of transcriptional repressors. However,
the gene specificity of these isoforms and their interactions
are yet to be elucidated.
HDAC regulation of metabolic gene
transcription
These mechanisms appear to regulate a number of meta-
bolic genes in skeletal muscle, as was recently demonstrated
in vitro, where human primary myotubes were acutely
treated with ScriptaidTM, a HDAC inhibitor. This resulted in
6- and 7-fold increases (p <0.05) in PGC-1 and GLUT4
mRNA, respectively (S.L. McGee and M. Hargreaves, un-
published). This not only demonstrates that some skeletal
muscle metabolic genes are regulated by HDACs, but also
reinforces that their regulation is a balance of HDAC and
HAT activities. Indeed, this is supported by the fact that
PGC-1 plays a large role in adaptive bioenergetics as a tran-
scriptional coactivator that recruits HAT enzymes to numer-
ous gene promoters (Knutti and Kralli 2001). Further
evidence that HDACs regulate metabolic gene expression
come from recent observations that overexpression of
HDAC5 in L6 myotubes results in repression of a number
of metabolic genes including GLUT4, PGC-1, cytochrome c
oxidase subunit 4, and carnitine palmitoyltransferase 1 (S.L.
McGee and K. Baar, unpublished). Furthermore, gene re-
porter assays using the human GLUT4 promoter region
tagged to the firefly luciferase gene show that HDAC5 re-
presses MEF2A-activated GLUT4 reporter gene activity.
Together, these data indicate that metabolic gene expression
is regulated by HDAC, and in particular HDAC5, activity.
This paradigm also appears to operate in human skeletal
muscle in response to exercise. Following 60 min of cycling
at *70% of VO2 peak, HDAC5 is dissociated from MEF2
and is exported from the nucleus (McGee and Hargreaves
2004). This is also associated with an increase in GLUT4
gene expression immediately after exercise. These data sug-
gest that HDAC5 could be a key regulator of exercise-
induced gene expression.
Regulation of HDAC5
As aberrant regulation of HDAC activity has become im-
plicated in an increasing number of disease states, efforts to
identify kinases capable of phosphorylating and regulating
the class II HDACs have also increased. In this regard,
most work has been performed on HDAC5. However, owing
to the high sequence homology between the regulatory phos-
phorylation sites on all class II HDACs, it is thought that
HDAC5 kinases are likely class II HDAC kinases (Chang et
al. 2005). Initially, the calcium/calmodulin-dependent pro-
tein kinases (CaMK) I and IV were found to phosphorylate
S259 and S498 on HDAC5 and to regulate HDAC5 activity
and localization (McKinsey et al. 2000). However, pharma-
cological inhibition of CaMK activity fails to totally abolish
HDAC5 kinase activity (McKinsey et al. 2002b), suggesting
redundancy in signaling to HDAC5. Furthermore, skeletal
muscle does not express CaMKI or IV (Rose et al. 2006).
This led us to hypothesize that the 5’-AMP-activated protein
kinase (AMPK) could be a potential HDAC5 kinase. AMPK
is a heterotrimeric protein consisting of a catalytic a and
regulatory b and g subunits that are activated in response to
metabolic stress via increases in the AMP to ATP ratio and
a number of hormones (Kahn et al. 2005). Allosteric activa-
tion of AMPK by AMP allows phosphorylation of T172 on
the catalytic a subunit by upstream kinases, such as the
LKB1–STRAD–MO25 complex, and augmentation of
AMPK activity. Exercise increases AMPK activity, and it is
thought that AMPK plays a key role in exercise metabolism
by increasing fatty acid oxidation and glucose uptake. Acti-
vation of AMPK has also been linked to exercise adapta-
tions in skeletal muscle (Jorgensen et al. 2006). Although
we have previously observed nuclear translocation of
AMPK during exercise in human skeletal muscle (McGee et
al. 2003), its physiological function in the nucleus was not
determined. In vitro kinase assays revealed that AMPK is a
HDAC5 kinase, and that S259 and S498 were required for
this response (S.L. McGee et al. unpublished). Furthermore,
this appears to be a functional relationship, as AMPK and
HDAC5 associate in vivo and treatment of human primary
myotubes with 5-aminoimidazole-4-carboxamide-b-D-ribo-
furanoside (AICAR), a pharmacological activator of AMPK,
induces HDAC5 nuclear export, which is consistent with
AMPK being a HDAC5 kinase. It also appears that AMPK
regulates metabolic gene expression through this mecha-
nism, as serine to alanine mutations of residues 259 and
498 on HDAC5 blocks induction of GLUT4 reporter gene
expression in response to AICAR treatment. This was also
assessed in an endogenous system through chromatin immu-
noprecipitation assays on AICAR-treated human primary
myotubes. In these experiments, the increase in AMPK ac-
tivity associated with AICAR treatment decreased the abun-
dance of HDAC5 found at the MEF2 binding region on the
GLUT4 promoter (S.L. McGee et al. unpublished). Collec-
tively, these data suggest that AMPK regulation of HDAC5
could be an important mechanism regulating exercise-
induced gene expression in skeletal muscle and reinforce
the important role of HDAC5 in this process.
Other HDAC kinases
Despite these findings, multiple research groups, using a
number of different animal models, have found that AMPK
is dispensable for exercise-induced expression of various
metabolic genes, thereby questioning the relevance of
AMPK in this response. However, in an elegant screen for
class II HDAC kinases, protein kinase D (PKD; also referred
to as PKCm) and microtubule affinity regulated kinase 2
(MARK2) were recently identified as novel class II HDAC
kinases (Chang et al. 2005), illustrating further redundancy
in HDAC signaling. Although originally categorized as a
member of the PKC family of kinases, the catalytic domain
of PKD shares high homology with the catalytic domains of
the CaMK family (Rozengurt et al. 2005). It does, however,
interact with diacylglycerol, produced at the plasma mem-
brane by a variety of stimuli, similar to PKCs. Upon inter-
acting with diacylglycerols, the catalytic domain of PKD is
exposed and phosphorylated by novel PKCs on S744 and
S748, resulting in autophosphorylation of serine 916. Phos-
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phorylation of this residue correlates well with PKD activity.
Once activated, PKD translocates to the nucleus, where it
can participate in transcriptional regulatory processes. PKD
has been implicated in membrane trafficking, cell survival,
differentiation and proliferation, and diseases such as cardiac
hypertrophy (Rozengurt et al. 2005), consistent with its role
as a class II HDAC kinase. MARK2 is a member of the
AMPK family of kinases and, like AMPK, is phosphorylated
on its activation loop (T211) by upstream kinases, including
the serine/threonine kinase LKB1 (Alessi et al. 2006).
MARK2 appears to regulate cell polarity and has been im-
plicated in the hyperphosphorylation of tau and therefore
Alzheimer’s disease (Kosuga et al. 2005). However,
MARK2 appears to be constitutively active, and recent anal-
ysis of MARK3 (Goransson et al. 2006) would suggest that
phosphorylation by atypical PKCs on multiple serine and
threonine residues provides binding sites for 14–3-3 proteins
that tether MARK2 to the cytosol to provide control over
MARK2 activity.
The contribution of these kinases to exercise-induced
gene expression is unclear; however, skeletal muscle
MARK2 activity has been assessed in response to in vitro
contractions, and consistent with previous studies in other
tissues, MARK2 activity was unchanged (Sakamoto et al.
2004). Although MARK2 localization was not assessed in
this study, it could suggest that MARK2 is not important
for transcriptional control during exercise. Nonetheless, we
are currently investigating the potential roles of PKD and
MARK2 on skeletal muscle metabolic gene regulation. Fur-
thermore, the potential role of CaMKII, the major CaMK
isoform expressed in muscle, also warrants investigation.
Exercise is known to increase skeletal muscle CaMKII ac-
tivity (Rose et al. 2006), and although it is not a HDAC5
kinase, CaMKII does phosphorylate HDAC4 (Backs et al.
2006) and could be the mechanism by which calcium signal-
ing participates in metabolic adaptation. Indeed, a recent pa-
per examining the regulation of hypertrophy genes in
cardiac tissue suggests a role for CaMKII in regulating
HDACs (Wu et al. 2006). It was found that nuclear CaMKII
was regulated by nuclear calcium fluxes that are dependent
on phospholipase C-derived inositol 1,4,5-triphosphate
(InsP3) and InsP3 receptors found at the nuclear envelope
(Wu et al. 2006). This mechanism for calcium sensing at
the nucleus is also independent of global calcium transients
that occur during excitation-contraction coupling, and
presents a potential mechanism for calcium-regulated gene
expression in skeletal muscle during exercise. Finally, the
role of phosphorylation-independent regulatory mechanisms
on metabolic gene regulation also needs to be elucidated.
Summary
Control of skeletal muscle metabolic gene transcription
appears to be regulated by the class IIa HDAC family of
transcriptional repressors, and in particular HDAC5. AMPK
and other HDAC5 kinases can regulate metabolic gene ex-
pression via regulation of HDAC5 activity and localization.
As HDAC5 dissociation with MEF2 and HDAC5 nuclear
export is observed during exercise, along with activation of
HDAC5 kinases such as AMPK (Fig. 1), it is possible that
these mechanisms participate in skeletal muscle adaptations
to exercise.
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